|
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study |
|
|
|
Titel: |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study |
Auteur: |
Lee, Michael S Ryoo, Baek-Yeol Hsu, Chih-Hung Numata, Kazushi Stein, Stacey Verret, Wendy Hack, Stephen P Spahn, Jessica Liu, Bo Abdullah, Heba Wang, Yulei He, Aiwu Ruth Lee, Kyung-Hun |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 21 () nr. 6 pagina's 808-820 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|